The Safety and Efficacy of Intra-Arterial versus Intravenous Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer: A Meta-Analysis

Table 2

Patient baseline characteristics.

Study	Patients enrolled	Histology type			Lymph node			Survival endpoints
		SCC	Adeno	Undifferentiated	Positive	Negative	Unknown
Saito et al. [11]	28	0	26	2	12	11	5	5-year survival 87.5%
Shibata et al. [12]	27	20	6	1	2	15	2	Disease-free survival 85.2%
Wen et al. [10]	57	53	4	0	12	16	29	3-yeat FPS 80.7%; 3-year OS 80.7%

SCC, squamous cell carcinoma; Adeno, adenocarcinoma; FPS, progression-free; OS, overall survival.